Table 3.
FSHD 1 (n = 463a) | Genetically confirmed (n = 298) | % of genetically confirmed reporting symptom (%) | |
---|---|---|---|
Hearing loss | |||
Yes/no (unknown) | 80/345 (38) | 54/222 (22) | 18.12 |
Retinal vascular diseaseb | |||
Yes/no (unknown) | 10/371 (65) | 9/230 (59) | 3.02 |
Current motor function | |||
Ambulant | 211 | 143 | 47.99 |
Ambulant with assistance | 171 | 112 | 37.58 |
Non-ambulant | 81 | 43 | 14.43 |
Wheelchair use | |||
Full-time | 82 | 45 | 15.10 |
Part-time | 103 | 65 | 21.82 |
None | 278 | 188 | 63.09 |
Facial weakness | 347 | 214 | 71.81 |
Scapular weakness | 428 | 270 | 90.60 |
Hip girdle weakness | 346 | 214 | 71.81 |
Foot drop | 341 | 215 | 72.15 |
a12 records excluded for missing or incomplete patient reported data
bAn additional 17 participants did not respond to the question about retinal vascular disease n = 446